Consolidated Statement of Cash Flows (IFRS)
for the years ended December 31,
|
Profit after taxes
|
1,848 |
1,908 |
| Adjustments to reconcile profit after taxes to net cash provided by operating activities: |
|
|
Depreciation and amortization
|
539 |
262 |
Gains/losses from at-equity investments
|
-1 |
1 |
Losses on disposal of intangible assets and property, plant, and equipment
|
11 |
1 |
Gains on disposal of investments
|
-15 |
-2 |
Writedowns of financial assets
|
15 |
8 |
Allowances for doubtful accounts
|
76 |
0 |
Impacts of hedging for cash-settled share-based payment plans
|
40 |
32 |
Share-based compensation including income tax benefits
|
19 |
13 |
Excess tax benefit from share-based compensation
|
-7 |
0 |
Deferred income taxes
|
-91 |
8 |
Change in accounts receivable
|
-48 |
-521 |
Change in other assets
|
-12 |
-277 |
Change in accrued and other liabilities
|
-277 |
375 |
Change in deferred income
|
61 |
124 |
Net cash provided by operating activities
|
2,158 |
1,932 |
| |
|
|
Acquisition of minority interests in subsidiaries
|
0 |
-48 |
Business combinations, net of cash and cash equivalents acquired
|
-3,773 |
-672 |
Repayment of acquirees' debt in business combinations
|
-450 |
0 |
Purchase of intangible assets and property, plant, and equipment
|
-339 |
-400 |
Proceeds from disposal of intangible assets and property, plant, and equipment
|
44 |
27 |
Cash transferred to restricted cash
|
-451 |
-550 |
Use of restricted cash
|
1,001 |
0 |
Purchase of investments
|
-380 |
-768 |
Sales of investments
|
579 |
1,025 |
Purchase of other financial assets
|
-16 |
-20 |
Sales of other financial assets
|
16 |
15 |
Net cash used in investing activities
|
-3,769 |
-1,391 |
| |
|
|
Dividends paid
|
-594 |
-556 |
Purchase of treasury stock
|
-487 |
-1,005 |
Proceeds from reissuance of treasury stock
|
85 |
156 |
Proceeds from issuance of common stock (share-based compensation)
|
13 |
44 |
| Excess tax benefit from share-based compensation |
7 |
0 |
Proceeds from short-term and long-term debt
|
3,859 |
47 |
Repayments of short-term and long-term debt
|
-1,571 |
-48 |
Proceeds from the exercise of equity-based derivative instruments (STAR hedge)
|
24 |
75 |
Purchase of equity-based derivative instruments (hedge for cash-settled
share-based payment plans)
|
-55 |
0 |
Net cash provided by/used in financing activities
|
1,281 |
-1,287 |
| |
|
|
Effect of foreign exchange rates on cash and cash equivalents
|
-1 |
-45 |
Net change in cash and cash equivalents
|
-331 |
-791 |
Cash and cash equivalents at the beginning of the period
|
1,608 |
2,399 |
Cash and cash equivalents at the end of the period
|
1,277 |
1,608 |